Vensana Capital recently announced that it has closed a $425 million Fund III for continued investment in innovative medtech ...

CapsoVision announced today that the FDA cleared its CapsoCam Plus system for use in pediatric patients aged two and above.

Pulse Biosciences announced today that it appointed Paul A. LaViolette, co-chair of its board, as its new CEO.

Relief Cardiovascular has closed a $12 million Series A round to help initiate a first-in-human feasibility study for its ...

Johnson & Johnson MedTech (NYSE: JNJ) announced that it received CE mark approval for its dual-energy ThermoCool SmartTouch ...

Saluda Medical announced that it closed a $100 million financing to support its novel closed-loop, dose-control ...

BD today announced it appointed Pamela Spikner as senior VP, chief accounting officer, and controller, effective January 20.